Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWAH 10639 is an amine-modified pteridine.1 It selectively inhibits T. gondii dihydrofolate reductase (DHFR; IC50 = 0.033 µM) over DHFR from the pathogenic yeast P. carinii and rat liver (IC50s = 0.2 and 1.1 µM, respectively). AH 10639 reduces T. gondii replication in T. gondii-infected MDBK bovine kidney cells with a mean significant inhibitory (MSI) concentration value of 1 µM and inhibits the uptake of para-aminobenzoic acid, a folate precursor, by P. carinii (IC50 = 16.2 µM). It increases survival in V. cholera-infected mice when administered at a dose of 500 mg/kg.2 AH 10639 reduces energy loss and increases thermal stability and power conversion efficiency, as well as improves interfacial contacts, when applied to the fullerene/cathode interface in inverted perovskite solar cells.3
WARNING This product is not for human or veterinary use.
1. 6,7-
2. Studies in the chemotherapy of cholera. VI. Protection by pteridines of mice infected with Vibrio cholerae. Ann. Trop. Med. Parasitol. 45(1), 58-61 (1951).
3. Simultaneous realization of bulk and interface regulation based on 2,4-